JP2008533150A5 - - Google Patents

Download PDF

Info

Publication number
JP2008533150A5
JP2008533150A5 JP2008501942A JP2008501942A JP2008533150A5 JP 2008533150 A5 JP2008533150 A5 JP 2008533150A5 JP 2008501942 A JP2008501942 A JP 2008501942A JP 2008501942 A JP2008501942 A JP 2008501942A JP 2008533150 A5 JP2008533150 A5 JP 2008533150A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
independently
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008501942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008533150A (ja
JP5052497B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/008943 external-priority patent/WO2006101808A1/en
Publication of JP2008533150A publication Critical patent/JP2008533150A/ja
Publication of JP2008533150A5 publication Critical patent/JP2008533150A5/ja
Application granted granted Critical
Publication of JP5052497B2 publication Critical patent/JP5052497B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008501942A 2005-03-17 2006-03-13 ヒスタミンh3受容体アンタゴニストとしてのピロリジン誘導体 Expired - Fee Related JP5052497B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66268605P 2005-03-17 2005-03-17
US60/662,686 2005-03-17
PCT/US2006/008943 WO2006101808A1 (en) 2005-03-17 2006-03-13 Pyrrolidine derivatives as histamine h3 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2008533150A JP2008533150A (ja) 2008-08-21
JP2008533150A5 true JP2008533150A5 (enExample) 2012-07-26
JP5052497B2 JP5052497B2 (ja) 2012-10-17

Family

ID=36642817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008501942A Expired - Fee Related JP5052497B2 (ja) 2005-03-17 2006-03-13 ヒスタミンh3受容体アンタゴニストとしてのピロリジン誘導体

Country Status (17)

Country Link
US (1) US7951826B2 (enExample)
EP (1) EP1861360B1 (enExample)
JP (1) JP5052497B2 (enExample)
CN (1) CN101142180B (enExample)
AT (1) ATE450503T1 (enExample)
AU (1) AU2006227815B2 (enExample)
BR (1) BRPI0608523A2 (enExample)
CA (1) CA2600757C (enExample)
CY (1) CY1109694T1 (enExample)
DE (1) DE602006010833D1 (enExample)
DK (1) DK1861360T3 (enExample)
ES (1) ES2335305T3 (enExample)
MX (1) MX2007011374A (enExample)
PL (1) PL1861360T3 (enExample)
PT (1) PT1861360E (enExample)
SI (1) SI1861360T1 (enExample)
WO (1) WO2006101808A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008301B2 (en) * 2004-04-01 2011-08-30 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
CA2688585A1 (en) * 2007-06-11 2008-12-18 F. Hoffmann-La Roche Ag Cyclohexyl derivatives
JP5377504B2 (ja) * 2007-10-17 2013-12-25 サノフイ 置換されたn−フェニル−ピロリジニルメチルピロリジンアミドおよびその治療的用途
RU2477720C2 (ru) 2007-10-17 2013-03-20 Санофи-Авентис Замещенные n-фенилбипирролидинкарбоксамиды и их применение в лечебных целях
HRP20110953T1 (hr) 2007-10-17 2012-01-31 Sanofi Supstituirani n-fenilbipirolidinkarboksamidi i njihova upotreba u terapiji
PL2215058T3 (pl) 2007-10-17 2012-04-30 Sanofi Sa Podstawione N-fenylo-bipirolidynomoczniki oraz ich zastosowanie terapeutyczne
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
CN103242212B (zh) * 2013-05-13 2015-11-04 南京理工大学 一种脑组胺h3受体放射性配体的前体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
AU721325B2 (en) 1995-05-30 2000-06-29 Gliatech Inc. 1H-4(5)-substituted imidazole derivatives
US5652258A (en) 1995-05-30 1997-07-29 Gliatech, Inc. 2-(4-imidazoyl) cyclopropyl derivatives
EP1379493A2 (en) * 2001-03-23 2004-01-14 Eli Lilly and Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
WO2003004480A2 (en) * 2001-07-02 2003-01-16 Novo Nordisk A/S Substituted piperazine and diazepanes as histamine h3 receptor agonists
GB0224084D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
US7696234B2 (en) * 2004-06-02 2010-04-13 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
WO2006044228A1 (en) * 2004-10-18 2006-04-27 Eli Lilly And Company Histamine h3 receptor inhibitors, preparation and therapeutic uses

Similar Documents

Publication Publication Date Title
JP2008510808A5 (enExample)
JP2008500997A5 (enExample)
JP2008509146A5 (enExample)
JP2005289914A5 (enExample)
JP2008533150A5 (enExample)
JP2015535277A5 (enExample)
JP2009504591A5 (enExample)
JP2008133278A5 (enExample)
JP2012140436A5 (ja) 物質
JP2010519270A5 (enExample)
JP2013040159A5 (ja) 有機金属錯体
JP2018520455A5 (enExample)
JP2005522505A5 (enExample)
JP2020500178A5 (enExample)
JP2007016214A5 (enExample)
EP2177556A3 (en) Silicone for preparing ophthalmic devices
JP2011227454A5 (enExample)
JP2009539914A5 (enExample)
JP2005511545A5 (enExample)
EP1826196A3 (en) Vinyl ether compounds
JP2008106051A5 (enExample)
JP2003151775A5 (enExample)
JP2004535412A5 (enExample)
JP2006527780A5 (enExample)
JP2008500416A5 (enExample)